Location: Home
  • search
  • go
  • News
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024 Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
  • 12/24/2024CDE Seeks Comments on the Supplementary List of External Experts for t...
  • 12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
  • 12/23/2024RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
  • 12/23/2024CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
  • 12/23/2024Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
  • 12/23/2024MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
  • 12/23/2024Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
  • 12/23/2024Shionogi Acquires Pingan's Stake in AI-Focused JVs
  • 12/22/2024Deputy NMPA Commissioner Attends GHWP Annual Meeting
  • 12/20/2024Recent Executive Moves
  • 12/20/2024China Licenses First Wholly Foreign-Owned Third-Grade General Hospital...
  • 12/20/2024CDE Issues the List of Reference Formulations for GQCE Studies (86th B...
  • 12/19/2024BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
  • 12/19/2024FDA Approves Betta/Xcovery's Ensartinib for NSCLC
  • 12/19/2024Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
  • 12/19/2024Aadi Partners with WuXi Bio and DAC for Next-Gen ADCs, Secures $100M P...
  • 12/18/2024Medical Costs in China Expected to Surge by 10.8% in 2025 amid Rising ...
  • 12/18/2024China, Japan and Korea Ink Key Agreements to Bolster Health Coopera...
  • 12/18/2024BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
  • 12/18/2024IFC Proposes $200M Loan to 3SBio to Improve Access in China and Develo...
  • 12/18/2024Merck and Hansoh Enter into Global License Deal for Investigational Or...
  • 12/18/2024Gan & Lee Cleared for the U.S. IND for Bi-weekly GLP-1RA GZR18 Injecti...
  • 12/17/2024Eli Lilly's Alzheimer's Drug Donanemab Secures Approval in China
  • 12/17/2024Lakeside Secures $1.5M Pharma Supply Deal in China
  • 12/16/2024NMPA Announces OTC Switch of Ketoprofen Patch
  • 12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
  • 12/16/2024Mabwell Plans Hong Kong Dual Listing Amid Shifting Market Dynamics  
  • Page:57/58 Total number of articles:1718: [First][<<] [54] [55] [56] [57] [58] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group